3,3',5,5'-tetramethylbenzidine and EHS Tumor

3,3',5,5'-tetramethylbenzidine has been researched along with EHS Tumor in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Filimonov, A; Filimonova, M; Ivanov, S; Kaprin, A; Koryakin, S; Makarchuk, V; Saburov, V; Saburova, A; Sevankaeva, L; Shegay, P; Shevchenko, L; Surinova, V; Yakovleva, N; Yuzhakov, V	1

Other Studies

1 other study(ies) available for 3,3',5,5'-tetramethylbenzidine and EHS Tumor

Article	Year
The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues. International journal of molecular sciences, 2021, Aug-28, Volume: 22, Issue:17 Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Gamma Rays; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Radiation Protection; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Thiourea	2021

Article

Year

The Ability of the Nitric Oxide Synthases Inhibitor T1023 to Selectively Protect the Non-Malignant Tissues.

International journal of molecular sciences, 2021, Aug-28, Volume: 22, Issue:17

Topics: Animals; Carcinoma, Ehrlich Tumor; Female; Gamma Rays; Male; Mice; Mice, Inbred ICR; Nitric Oxide Synthase; Radiation Protection; Radiation-Protective Agents; Radiodermatitis; Rats; Rats, Sprague-Dawley; Sarcoma, Experimental; Thiourea

2021